Global and United States Aprepitant Market Report & Forecast 2024-2031

Report ID: 1830330 | Published Date: Jan 2025 | No. of Page: 71 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Aprepitant Product Introduction
    1.2 Global Aprepitant Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Aprepitant Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Aprepitant Sales in Volume for the Year 2017-2028
    1.3 United States Aprepitant Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Aprepitant Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Aprepitant Sales in Volume for the Year 2017-2028
    1.4 Aprepitant Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Aprepitant in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Aprepitant Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Aprepitant Market Dynamics
        1.5.1 Aprepitant Industry Trends
        1.5.2 Aprepitant Market Drivers
        1.5.3 Aprepitant Market Challenges
        1.5.4 Aprepitant Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Aprepitant Market Segment by Type
        2.1.1 Injection
        2.1.2 Oral
    2.2 Global Aprepitant Market Size by Type
        2.2.1 Global Aprepitant Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Aprepitant Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Aprepitant Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Aprepitant Market Size by Type
        2.3.1 United States Aprepitant Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Aprepitant Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Aprepitant Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Aprepitant Market Segment by Application
        3.1.1 Hospital
        3.1.2 Drug store
    3.2 Global Aprepitant Market Size by Application
        3.2.1 Global Aprepitant Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Aprepitant Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Aprepitant Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Aprepitant Market Size by Application
        3.3.1 United States Aprepitant Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Aprepitant Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Aprepitant Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Aprepitant Competitor Landscape by Company
    4.1 Global Aprepitant Market Size by Company
        4.1.1 Top Global Aprepitant Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Aprepitant Revenue by Manufacturer (2017-2022)
        4.1.3 Global Aprepitant Sales by Manufacturer (2017-2022)
        4.1.4 Global Aprepitant Price by Manufacturer (2017-2022)
    4.2 Global Aprepitant Concentration Ratio (CR)
        4.2.1 Aprepitant Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Aprepitant in 2021
        4.2.3 Global Aprepitant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Aprepitant Manufacturing Base Distribution, Product Type
        4.3.1 Global Aprepitant Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Aprepitant Product Type
        4.3.3 Date of International Manufacturers Enter into Aprepitant Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Aprepitant Market Size by Company
        4.5.1 Top Aprepitant Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Aprepitant Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Aprepitant Sales by Players (2020, 2021 & 2022)
5 Global Aprepitant Market Size by Region
    5.1 Global Aprepitant Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Aprepitant Market Size in Volume by Region (2017-2028)
        5.2.1 Global Aprepitant Sales in Volume by Region: 2017-2022
        5.2.2 Global Aprepitant Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Aprepitant Market Size in Value by Region (2017-2028)
        5.3.1 Global Aprepitant Sales in Value by Region: 2017-2022
        5.3.2 Global Aprepitant Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Aprepitant Market Size YoY Growth 2017-2028
        6.1.2 North America Aprepitant Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Aprepitant Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Aprepitant Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Aprepitant Market Size YoY Growth 2017-2028
        6.3.2 Europe Aprepitant Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Aprepitant Market Size YoY Growth 2017-2028
        6.4.2 Latin America Aprepitant Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Aprepitant Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Aprepitant Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Merck & Co.
        7.1.1 Merck & Co. Corporation Information
        7.1.2 Merck & Co. Description and Business Overview
        7.1.3 Merck & Co. Aprepitant Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Merck & Co. Aprepitant Products Offered
        7.1.5 Merck & Co. Recent Development
    7.2 Heron Therapeutics
        7.2.1 Heron Therapeutics Corporation Information
        7.2.2 Heron Therapeutics Description and Business Overview
        7.2.3 Heron Therapeutics Aprepitant Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Heron Therapeutics Aprepitant Products Offered
        7.2.5 Heron Therapeutics Recent Development
    7.3 Sandoz
        7.3.1 Sandoz Corporation Information
        7.3.2 Sandoz Description and Business Overview
        7.3.3 Sandoz Aprepitant Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Sandoz Aprepitant Products Offered
        7.3.5 Sandoz Recent Development
    7.4 Glenmark Pharmaceuticals
        7.4.1 Glenmark Pharmaceuticals Corporation Information
        7.4.2 Glenmark Pharmaceuticals Description and Business Overview
        7.4.3 Glenmark Pharmaceuticals Aprepitant Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Glenmark Pharmaceuticals Aprepitant Products Offered
        7.4.5 Glenmark Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Aprepitant Industry Chain Analysis
    8.2 Aprepitant Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Aprepitant Distributors
    8.3 Aprepitant Production Mode & Process
    8.4 Aprepitant Sales and Marketing
        8.4.1 Aprepitant Sales Channels
        8.4.2 Aprepitant Distributors
    8.5 Aprepitant Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Aprepitant CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Aprepitant Market Trends
    Table 3. Aprepitant Market Drivers
    Table 4. Aprepitant Market Challenges
    Table 5. Aprepitant Market Restraints
    Table 6. Global Aprepitant Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Aprepitant Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Aprepitant Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Aprepitant Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Aprepitant Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Aprepitant Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Aprepitant Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Aprepitant Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Aprepitant Sales Share by Manufacturer, 2017-2022
    Table 15. Global Aprepitant Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Aprepitant Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Aprepitant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aprepitant as of 2021)
    Table 18. Top Players of Aprepitant in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Aprepitant Product Type
    Table 20. Date of International Manufacturers Enter into Aprepitant Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Aprepitant Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Aprepitant Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Aprepitant Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Aprepitant Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Aprepitant Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Aprepitant Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Aprepitant Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Aprepitant Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Aprepitant Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Aprepitant Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Aprepitant Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Aprepitant Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Aprepitant Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Aprepitant Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Aprepitant Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Aprepitant Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Aprepitant Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Aprepitant Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Aprepitant Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Aprepitant Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Merck & Co. Corporation Information
    Table 43. Merck & Co. Description and Business Overview
    Table 44. Merck & Co. Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Merck & Co. Aprepitant Product
    Table 46. Merck & Co. Recent Development
    Table 47. Heron Therapeutics Corporation Information
    Table 48. Heron Therapeutics Description and Business Overview
    Table 49. Heron Therapeutics Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Heron Therapeutics Product
    Table 51. Heron Therapeutics Recent Development
    Table 52. Sandoz Corporation Information
    Table 53. Sandoz Description and Business Overview
    Table 54. Sandoz Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Sandoz Product
    Table 56. Sandoz Recent Development
    Table 57. Glenmark Pharmaceuticals Corporation Information
    Table 58. Glenmark Pharmaceuticals Description and Business Overview
    Table 59. Glenmark Pharmaceuticals Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Glenmark Pharmaceuticals Product
    Table 61. Glenmark Pharmaceuticals Recent Development
    Table 62. Key Raw Materials Lists
    Table 63. Raw Materials Key Suppliers Lists
    Table 64. Aprepitant Customers List
    Table 65. Aprepitant Distributors List
    Table 66. Research Programs/Design for This Report
    Table 67. Key Data Information from Secondary Sources
    Table 68. Key Data Information from Primary Sources
List of Figures
    Figure 1. Aprepitant Product Picture
    Figure 2. Global Aprepitant Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Aprepitant Market Size 2017-2028 (US$ Million)
    Figure 4. Global Aprepitant Sales 2017-2028 (K Units)
    Figure 5. United States Aprepitant Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Aprepitant Market Size 2017-2028 (US$ Million)
    Figure 7. United States Aprepitant Sales 2017-2028 (K Units)
    Figure 8. United States Aprepitant Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Aprepitant Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Aprepitant Report Years Considered
    Figure 11. Product Picture of Injection
    Figure 12. Product Picture of Oral
    Figure 13. Global Aprepitant Market Share by Type in 2022 & 2028
    Figure 14. Global Aprepitant Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Aprepitant Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Aprepitant Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Aprepitant Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Aprepitant Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Aprepitant Market Share by Type in 2022 & 2028
    Figure 20. United States Aprepitant Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Aprepitant Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Aprepitant Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Aprepitant Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Aprepitant Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Hospital
    Figure 26. Product Picture of Drug store
    Figure 27. Global Aprepitant Market Share by Application in 2022 & 2028
    Figure 28. Global Aprepitant Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Aprepitant Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Aprepitant Sales by Application (2017-2028) & (K Units)
    Figure 31. Global Aprepitant Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Aprepitant Price by Application (2017-2028) & (USD/Unit)
    Figure 33. United States Aprepitant Market Share by Application in 2022 & 2028
    Figure 34. United States Aprepitant Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Aprepitant Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Aprepitant Sales by Application (2017-2028) & (K Units)
    Figure 37. United States Aprepitant Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Aprepitant Price by Application (2017-2028) & (USD/Unit)
    Figure 39. North America Aprepitant Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America Aprepitant Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Aprepitant Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. Europe Aprepitant Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Aprepitant Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Asia-Pacific Aprepitant Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Aprepitant Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Aprepitant Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Aprepitant Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Aprepitant Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. U.A.E Aprepitant Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Aprepitant Value Chain
    Figure 73. Aprepitant Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck & Co.
Heron Therapeutics
Sandoz
Glenmark Pharmaceuticals
Frequently Asked Questions
Aprepitant report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Aprepitant report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Aprepitant report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Tiotropium bromide

Tiotropium bromide market is segmented by region (country), players, by Type and by Application.  ... Read More